<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Kleine-Levin syndrome (recurrent hypersomnia)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Kleine-Levin syndrome (recurrent hypersomnia)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Kleine-Levin syndrome (recurrent hypersomnia)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Pauline Dodet, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Emmanuel Mignot, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Isabelle Arnulf, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas E Scammell, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ronald D Chervin, MD, MS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H18536139"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Kleine-Levin syndrome (KLS), also called recurrent hypersomnia or periodic hypersomnolence, is a rare sleep disorder characterized by recurrent episodes of severe hypersomnia associated with cognitive and behavioral disturbances such as confusion, derealization, apathy, compulsive eating, and hypersexuality. Episodes last a few days to several weeks and are separated by weeks or months of normal sleep and behavior.</p><p>KLS is categorized as a central disorder of hypersomnolence; other disorders in this category include narcolepsy type 1 and type 2 and idiopathic hypersomnia. (See  <a class="medical medical_review" href="/d/html/7700.html" rel="external">"Classification of sleep disorders"</a>.)</p><p>The epidemiology, pathogenesis, clinical features, diagnosis, and treatment of KLS will be reviewed here. A general approach to the patient with excessive daytime sleepiness and other central disorders of hypersomnolence are discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/97853.html" rel="external">"Clinical features and diagnosis of narcolepsy in children"</a> and  <a class="medical medical_review" href="/d/html/131001.html" rel="external">"Management and prognosis of narcolepsy in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7689.html" rel="external">"Clinical features and diagnosis of narcolepsy in adults"</a> and  <a class="medical medical_review" href="/d/html/7681.html" rel="external">"Treatment of narcolepsy in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14890.html" rel="external">"Idiopathic hypersomnia"</a>.)</p><p></p><p class="headingAnchor" id="H11387268"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Kleine-Levin syndrome (KLS) is a rare disorder with an estimated prevalence of one to five cases per million population [<a href="#rid1">1-7</a>]. Patients with primary KLS can be found worldwide, with a higher prevalence among individuals with Ashkenazi Jewish ancestry in the United States. (See <a class="local">'Etiology and pathogenesis'</a> below.)</p><p>KLS is more common in males than females. In several large observational series, the proportion of males ranges from 60 to 87 percent [<a href="#rid3">3-7</a>].</p><p class="headingAnchor" id="H958107"><span class="h1">ETIOLOGY AND PATHOGENESIS</span><span class="headingEndMark"> — </span>The etiology of Kleine-Levin syndrome (KLS) is unknown. Although a psychological basis was considered most likely when the disorder was first described, contemporary hypotheses have focused primarily on genetic and immune/inflammatory-mediated causes. There is also an association between KLS and a history of birth and developmental abnormalities.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Birth difficulties </strong>– An abnormal birth history (eg, long labor, hypoxia, premature or postmature birth) is reported by 25 percent of patients. Developmental delay or learning difficulties such as dyslexia, dysorthographia, or dyscalculia are found in an additional 15 percent of patients with KLS [<a href="#rid4">4,7</a>]. Overall, approximately one-third of patients with KLS have an abnormal birth or developmental history.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic factors </strong>– A genetic basis for the disorder has been suggested by the preponderance of cases in the Ashkenazi Jewish population, suggesting a founder effect, as well as the existence of familial clustering and monozygotic twins with the disorder [<a href="#rid2">2,4,7-18</a>].</p><p></p><p class="bulletIndent1">In the largest multiplex family described, a father, three sons, and two daughters were affected [<a href="#rid11">11</a>]. Exome analysis identified a heterozygous missense variant in <em>LMOD3</em>, a gene implicated in brain development, as a candidate gene [<a href="#rid19">19</a>], but an association was not reproduced in another cohort. A large, worldwide study of 673 sporadic KLS cases has identified <em>TRANK1</em> as a candidate gene when associated with birth difficulties and developmental delay [<a href="#rid20">20</a>]. The genetic data also suggest some association with circadian genes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precipitating factors</strong> – A variety of precipitating factors have been reported in patients with KLS. Disease onset is often closely associated with one or more health events or exposures, such as infection (72 percent), alcohol ingestion (23 percent), sleep deprivation (22 percent), unusual stress (20 percent), and physical exertion (19 percent) [<a href="#rid4">4</a>]. Other precipitating factors may include substance use (eg, cannabis, cocaine, gamma-hydroxybutyrate), head trauma, and vaccinations [<a href="#rid3">3-7,21-26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infectious and immune-mediated theories</strong> – An infectious, inflammatory, or immune-mediated etiology has been hypothesized based on frequent reports of infection-like symptoms at disease onset, but no specific antigens or autoantibodies have yet been identified [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">Focal viral encephalitis or postinfectious inflammatory or autoimmune encephalitis affecting specific areas of the brain (ie, thalamus-hypothalamus, frontal and temporal lobes) would be consistent with the nature of the disease. These structures have a pivotal role in the regulation of sleep, perception, mood, and impulse control, and KLS-like symptoms can occur in association with hypothalamic, frontal, and temporal lobe tumors [<a href="#rid28">28,29</a>]. However, evidence for such pathology in the brains of KLS patients remains elusive. (See <a class="local">'Neuroimaging'</a> below.)</p><p></p><p class="bulletIndent1">In most cases of apparently infection-triggered KLS, symptoms of KLS occur between one and five days after the onset of fever. Agents responsible for the infection are rarely identified and highly variable, however, and the interval to episode onset is too short for most immune-mediated processes. Specific infections reported in association with KLS include Epstein-Barr virus, varicella zoster, herpes zoster, influenza A and B, adenovirus, enterovirus, H1N1, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), <em>Salmonella typhi</em>, and <em>Streptococcus</em> [<a href="#rid3">3,4,6,7,26,30-35</a>]. The heterogeneity of identified agents suggests no direct effect [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Associated conditions</strong> – A wide variety of genetic disorders have been reported with increased frequency in patients with KLS, including Klinefelter syndrome, von Willebrand syndrome, polycystic kidneys, and autism spectrum disorders  (<a class="graphic graphic_table graphicRef98009" href="/d/graphic/98009.html" rel="external">table 1</a>) [<a href="#rid4">4,5,36,37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuropathologic findings</strong> – Neuropathologic studies of KLS are limited to four case reports. In two cases of primary KLS, the following findings were described:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe inflammation of the thalamus and mild inflammation of the hypothalamus were described in a 46-year-old man who died from aspiration pneumonia during an attack of hyperphagia [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 17-year-old male with a classic form of KLS and autonomic dysfunction during attacks died from cardiopulmonary arrest during an attack [<a href="#rid39">39</a>]. The neuropathologic examination revealed mild depigmentation of the substantia nigra and locus coeruleus. The cortex, thalamus, and hypothalamus were normal.</p><p></p><p class="bulletIndent1">In two other reported cases, symptoms of KLS appeared to be secondary to a paraneoplastic syndrome, with abnormalities in the hypothalamus, amygdala, and gray matter of the temporal lobes [<a href="#rid40">40</a>], or inflammatory encephalitis within the thalamus and hypothalamus [<a href="#rid41">41</a>].</p><p></p><p class="headingAnchor" id="H11387275"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H969660"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>The median age of onset of KLS is 16 years [<a href="#rid4">4</a>]. Approximately 80 percent of patients present during the second decade of life [<a href="#rid3">3-5</a>], with a range of 4 to 82 years [<a href="#rid42">42,43</a>]. Patients with late onset (&gt;35 years) usually have typical symptoms but tend to have longer episodes [<a href="#rid26">26,38,43-47</a>], while childhood onset (&lt;12 years) is associated with more frequent episodes [<a href="#rid3">3,4,48-51</a>]. In one large series, females were older at onset than males (18.5 versus 15.0 years), despite an earlier onset of puberty (11.8 versus 13.2 years) [<a href="#rid4">4</a>].</p><p>Symptom severity during each episode tends to progress rapidly, within hours to days, and symptoms last for a median of 10 days [<a href="#rid3">3,4,8,52</a>]. There is a broad range, however, and episodes can last for a few days in mild cases to several weeks or even months in more severe cases. Milder cases of KLS have one to three short episodes per year, but moderate cases can have monthly episodes of 7 to 10 days each [<a href="#rid3">3,4,30</a>].</p><p>Prolonged episodes (eg, four weeks or longer) have been described in approximately one-third of patients and are associated with higher levels of anxiety, agitation, and amnesia compared with shorter episodes [<a href="#rid7">7</a>]. In severe cases, patients can experience 40 to 80 episodes in a rapid succession, with a possible permanent impairment of attention and mood [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H955439"><span class="h2">Cardinal symptoms</span><span class="headingEndMark"> — </span>Episodic hypersomnia is the defining feature of KLS. Additional symptoms present in most patients during episodes of hypersomnia include cognitive disturbance, an altered perceptive state, referred to as derealization, severe apathy, and disinhibition.</p><p class="headingAnchor" id="H11387281"><span class="h3">Hypersomnia</span><span class="headingEndMark"> — </span>Hypersomnia is a major clinical symptom of KLS and is mandatory for the diagnosis [<a href="#rid53">53</a>]. Hypersomnia as used here refers to an increase in actual sleep time and is distinct from symptoms of sleepiness, fatigue, or low energy. Sleep is enormously increased during episodes, with a median total sleep time of 18 hours per day [<a href="#rid3">3,4</a>], sometimes with loss of the normal circadian rhythm of sleep [<a href="#rid8">8</a>].</p><p>Most patients are difficult to awaken and report intense dreaming and hypnagogic hallucinations; sleep paralysis is uncommon. The need for sleep is so intense that patients may be found sleeping in the hallway outside a classroom or on the sidewalk [<a href="#rid54">54-56</a>]. Patients remain arousable, waking up spontaneously to void and eat, but are usually irritable or aggressive when awakened or prevented from sleeping.</p><p>There is frequently a brief overshoot of insomnia at the end of an episode. This insomnia is sometimes associated with euphoria [<a href="#rid4">4,44,57,58</a>]. The need for sleep and total sleep time tend to diminish during later episodes [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H11387293"><span class="h3">Cognitive disturbance</span><span class="headingEndMark"> — </span>Cognitive disturbance is the second most common symptom after hypersomnia. Patients are slow to understand and respond to questions. They do not initiate spontaneous speech, and they answer with monosyllabic or short sentences [<a href="#rid3">3,4</a>].</p><p>Memory disturbances are common, and the majority of patients report incomplete recollection of episodes. Temporal and spatial disorientation is common. Eye-hand coordination may be slower. Simple gestures, such as finding one's key in a pocket, may be difficult. This may be due to abnormal perception of objects with touch (astereognosia). </p><p>Formal cognitive and memory tests have been rarely performed during a KLS episode, and their validity is questionable as patients can be uncooperative, irritable, sleepy, and inattentive [<a href="#rid59">59-61</a>].</p><p>In between episodes, most patients are described as completely normal. With formal testing, however, patients with KLS score lower than age-matched controls on nonverbal intelligence quotient (IQ), processing speed, attention, and episodic memory retrieval [<a href="#rid26">26,29,59,62-65</a>]. In one large study, episodic memory performance declined after a mean follow-up of 1.7 years, despite a decrease in yearly episode frequency [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H956272"><span class="h3">Derealization</span><span class="headingEndMark"> — </span>During episodes, sensations of unreality are common and are probably the most specific symptom of the syndrome [<a href="#rid4">4</a>]. Surroundings are seemingly wrong, distorted, or unreal. Perception of sight, sound, smell, taste, temperature, and pain can all feel abnormal or unreal. Objects and voices are perceived to be distant [<a href="#rid49">49,66</a>]. The symptom has been described by patients with KLS in various ways [<a href="#rid8">8,67,68</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>"Unpleasant perception, bizarre and wrong"</p><p class="bulletIndent1"><span class="glyph">●</span>"A nightmarish sense of the surroundings"</p><p class="bulletIndent1"><span class="glyph">●</span>"The feeling of being almost in a dream"</p><p class="bulletIndent1"><span class="glyph">●</span>"Feelings of depersonalization, anguish, and a belief of a split between mind and body"</p><p></p><p>In one cross-sectional series, derealization was both sensitive (100 percent of patients reported it) and specific, as it was not reported in patients with other sleep or psychiatric diseases [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H2088798592"><span class="h3">Apathy</span><span class="headingEndMark"> — </span>Apathy is one of the major and most frequent symptoms during KLS episodes, reported by more than 90 percent of patients, often to the point of frank abulia [<a href="#rid7">7</a>]. Patients and families report the absence of self-motivation for almost all activities, including reading, watching television, using cell phones, and social communication of any type. Approximately 80 percent of patients neglect their hygiene during episodes.</p><p class="headingAnchor" id="H3306724076"><span class="h3">Disinhibition</span><span class="headingEndMark"> — </span>Although hyperphagia and hypersexuality have traditionally been considered hallmark clinical features, these symptoms are more variable across patients and episodes than previously thought and are better viewed as expressions of general disinhibition.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Change in eating behaviors</strong> — Most patients report abnormal eating during at least one episode. Approximately two-thirds of patients have hyperphagia (eating large amounts of food at each meal, also referred to as megaphagia). The disinhibited eating is often directed towards specific tastes (eg, sweet, salty, or sour), even if these are atypical food choices for the individual. Other patients would eat any and all food before them, behavior that is reminiscent of frontal lobe syndromes. There are reports of patients who stole food in shops or off the plates of other patients [<a href="#rid56">56,69,70</a>], who searched for food in waste baskets [<a href="#rid56">56</a>], or who stuffed food in their mouths with both hands [<a href="#rid71">71</a>].</p><p></p><p class="bulletIndent1">Hyperphagia and inactivity often lead to striking weight gain: 4.6 kg/episode in one large study [<a href="#rid4">4</a>] and 3.2 to 13.6 kg/episode in another [<a href="#rid3">3</a>]. Notably, however, up to one-third of patients have decreased appetite or eat less during some episodes [<a href="#rid4">4,6,47,72,73</a>]. These patients usually have a more severe hypersomnia, compared with those with hyperphagia.</p><p></p><p class="bulletIndent1">The eating habits of patients with KLS are distinct from those of patients with bulimia in that there are no periods with self-induced vomiting or other attempts to control weight.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypersexuality</strong> — Approximately half of males and one-third of females have hypersexuality during at least one episode [<a href="#rid4">4,6</a>]. Hypersexuality occasionally occurs in prepubescent children [<a href="#rid49">49,51,74</a>].</p><p></p><p class="bulletIndent1">Symptoms include increased masturbation and inappropriate sexual behaviors such as exposing or touching genitals, masturbating in the presence of parents/caregivers and clinicians, use of obscene language, or touching other people inappropriately [<a href="#rid45">45</a>]. Although hypersexuality is often emphasized as a key symptom of KLS, it likely represents just one aspect of disinhibition that is characteristic of KLS episodes. A less specific behavioral disinhibition is more common [<a href="#rid4">4,6</a>].</p><p></p><p class="headingAnchor" id="H3721063848"><span class="h3">Others</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mood disturbances</strong> – Approximately half of patients with KLS have depressed mood during episodes, a finding significantly more frequent in females [<a href="#rid3">3,4</a>]. Suicidal ideation has been reported in up to 18 percent of patients, often expressed as a desire to bring an end to the episode. Suicide attempts have been reported but appear to be rare, possibly because of severe apathy associated with episodes [<a href="#rid44">44,75,76</a>].</p><p></p><p class="bulletIndent1">Patients are often anxious, scared of being left alone or of answering phone calls, or afraid of novelty in their environment. They usually refuse to visit friends or families or to receive visitors, mostly saying that they do not want to be seen in this state.</p><p></p><p class="bulletIndent1">Irritability is present in almost all patients, especially when sleep or food intake is prohibited. Aggressive behavior, such as biting, spitting, throwing stones, or tantrums at school, is rare [<a href="#rid47">47,54,56,68,77</a>]. Some patients exhibit regressive behaviors such as using childish words and voice or asking a parent/caregiver to sleep nearby [<a href="#rid4">4,78</a>].</p><p></p><p class="bulletIndent1">In most cases, mood disturbances resolve by the end of the episode, although in rare cases they persist longer. A period of hypomania is not uncommon at the conclusion of an episode, extending over a day or two [<a href="#rid79">79,80</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hallucinations and delusions</strong> – One-third of patients report brief, elementary hallucinations (eg, seeing a snake near the bed, hearing their name, but no insulting content). Delusions of reference are also commonly reported (eg, a feeling of being scrutinized by others) [<a href="#rid76">76</a>]. In rare cases, persecutory delusions and delusions of grandeur are severe and lead to a misdiagnosis of schizophrenia. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Compulsive behaviors</strong> – Compulsions are reported in approximately one-third of patients. Examples include inappropriate singing, tapping, clapping, compulsive writing on walls, stripping down wallpaper, pacing, wringing hands, and tearing out hair [<a href="#rid17">17,54,60,67,71,81-86</a>]. Some patients repeatedly listen to music or watch the same videos over and over again [<a href="#rid4">4,6,60,83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical symptoms</strong> – Fever, photophobia, and headache were endorsed by half of patients in one retrospective series, without stiff neck [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1">In a series of 108 patients questioned retrospectively about autonomic symptoms during an episode, 46 percent recalled sweating, 24 percent reported hot flashes, and 18 percent had nausea [<a href="#rid4">4</a>]. There have been rare reports of flushed face [<a href="#rid57">57</a>], thermoregulatory changes [<a href="#rid26">26</a>], hyperventilation [<a href="#rid87">87</a>], short episodes of flushes, profuse sweating, excessive salivation, hypertension and tachycardia [<a href="#rid46">46</a>], and hypotension and bradycardia [<a href="#rid39">39,47,83,88</a>].</p><p></p><p class="headingAnchor" id="H983012"><span class="h2">Menstrual recurrent hypersomnia</span><span class="headingEndMark"> — </span>Menstrual recurrent hypersomnia (MRH) is a rare variant of recurrent hypersomnia [<a href="#rid53">53</a>], identified in less than 20 women so far [<a href="#rid5">5</a>]. A pathophysiologic association between MRH and KLS is supported by report of a family with a daughter with MRH and a son with KLS [<a href="#rid12">12</a>]. Moreover, some girls with typical KLS have most of their episodes (but not all) in association with menstruation, making the differentiation between typical KLS and MRH difficult [<a href="#rid26">26,89</a>]. As a consequence, the third edition of the International Classification of Sleep Disorders (ICSD-3) considers MRH as a variant of KLS [<a href="#rid53">53</a>].</p><p>Episodes of hypersomnia occur just before or during menstruation and are associated with compulsive eating (65 percent), depressed mood (35 percent), and sexual disinhibition (29 percent) [<a href="#rid5">5</a>]. Compared with typical KLS, episodes of menstrual recurrent hypersomnia are usually shorter (3 to 15 days), less frequently involve cognitive changes, and sometimes respond to treatment with combined estrogen-progestin oral contraceptives [<a href="#rid5">5,90,91</a>].</p><p class="headingAnchor" id="H1542936357"><span class="h2">Laboratories and studies</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cerebrospinal fluid</strong> – During and between episodes, the CSF in patients with KLS is normal. This includes both basic CSF parameters (eg, cell counts, glucose, total protein) as well as immunoelectrophoresis for oligoclonal bands [<a href="#rid51">51,54,92,93</a>]. No consistent alterations in neurotransmitter levels or dopamine and serotonin metabolism have been identified [<a href="#rid38">38,39,50,94-96</a>].</p><p></p><p class="bulletIndent1">CSF levels of hypocretin-1 (orexin) are usually within normal range (above 110 pmol/L) during episodes [<a href="#rid8">8,97-100</a>], although they are one-third lower during symptomatic versus asymptomatic periods. Such levels do not explain the major hypersomnia during episodes but suggest a possible secondary role of hypocretin-1 in pathogenesis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electroencephalography</strong> – Electroencephalogram (EEG) findings in patients with KLS are nonspecific. There is no evidence of seizure activity during episodes, even when sphenoid electrodes are placed. In 70 percent of patients who undergo EEG during episodes of hypersomnia, a nonspecific, diffuse slowing (7 to 8 Hz) of background EEG activity is observed [<a href="#rid3">3</a>]. Less often, low-frequency, high-amplitude waves (delta or theta) are observed, mainly in bilateral temporal or frontotemporal areas.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polysomnography</strong> – Polysomnography findings during an episode of hypersomnia are variable and may be affected by the duration of monitoring (ie, 12 versus 24 hours) and the timing of the study in relation to the episode and disease onset [<a href="#rid1">1-3,101</a>]. Total sleep time is generally increased, ranging from approximately 9 to 12 hours, but sleep structure is essentially normal [<a href="#rid1">1,2</a>].</p><p></p><p class="bulletIndent1">Less consistent abnormalities that have been described in one or more studies include a mild reduction in slow-wave sleep during the first half of an episode, mild reduction in sleep efficiency due to frequent awakenings during non-rapid eye movement (NREM) stages 1 to 2, and reduced NREM stage 3 and 4 duration.</p><p></p><p class="bulletIndent1">In 19 patients with KLS, approximately 40 percent of patients demonstrated a narcolepsy-like pattern, with two or more sleep-onset REM periods during multiple sleep latency test [<a href="#rid101">101</a>]. Reduced sleep latency is not a universal finding, however. In other cases, the duration of sleep stages during daytime sleep contains an excess of NREM stages 1 to 2 [<a href="#rid3">3</a>]. In 20 children with KLS, the amplitude and the stability of the circadian rest-active rhythms drastically decreased, as patients were lying down and inactive most of the day [<a href="#rid102">102</a>]. </p><p></p><p class="bulletIndent1">Of note, polysomnographic findings may vary according to the stage of the disease. In one study, sleep studies obtained later in the disease course demonstrated that patients spent three to nine hours per day in a state of withdrawal with their eyes closed and an EEG pattern that resembled their awake state [<a href="#rid103">103</a>].</p><p></p><p class="headingAnchor" id="H2708123543"><span class="h2">Neuroimaging</span><span class="headingEndMark"> — </span>Structural brain computed tomography (CT) and magnetic resonance imaging (MRI) studies are normal in patients with KLS [<a href="#rid1">1-3,104</a>]. Although various minor abnormalities have been reported (eg, frontal cysts, local atrophy), they are likely incidental findings [<a href="#rid64">64</a>].</p><p>By contrast, functional and perfusion-based imaging studies are frequently abnormal in patients with KLS both during and between episodes. Case reports and small case series have described a variety of abnormalities on single-photon emission computed tomography (SPECT), positron emission tomography (PET), and functional MRI [<a href="#rid6">6,59,104-106</a>]. The most consistent finding in studies using visual or semiquantitative analysis is reduced temporal/frontotemporal lobe perfusion, found in approximately half of patients; the thalamus, parietotemporal junction, and association cortex are also commonly involved. During asymptomatic periods, hypometabolism in the posterior associative cortex and hippocampus on PET may emerge as a useful clinical marker during the early phase of illness [<a href="#rid107">107</a>].</p><p>Persistent hypoperfusion in the diencephalic and associative cortical area during asymptomatic periods [<a href="#rid104">104</a>] may be a marker of complex thalamocortical circuit dysfunction, compensated by supplemental activation of other areas [<a href="#rid108">108</a>]. The altered brain activation pattern in KLS patients has been accompanied by lower performance levels and longer reaction times [<a href="#rid61">61,108-110</a>].</p><p class="headingAnchor" id="H3993034474"><span class="h1">CLINICAL COURSE</span><span class="headingEndMark"> — </span>Episodes of Kleine-Levin syndrome (KLS) tend to decrease in frequency and intensity over time, especially prior to disease termination.</p><p>Disease duration from the first to the last episode is extremely variable, with a spectrum ranging from 6 months to 41 years [<a href="#rid3">3</a>]. In a series of 110 patients with KLS, the median disease duration was eight years [<a href="#rid3">3</a>]. In another survey of 108 new KLS cases, the mean disease duration was 14 years, and approximately 15 percent of patients had a disease course longer than 25 years [<a href="#rid4">4</a>]. Risk factors for a longer disease course were male sex, hypersexuality, and onset after age 20 years.</p><p>In between episodes, patients with KLS typically return to a normal baseline. However, functional imaging studies and long-term neuropsychological and psychiatric follow-up in a growing number of patients suggest that there may be mild, long-lasting memory and attention defects [<a href="#rid3">3,62-64,108-113</a>]. (See <a class="local">'Cognitive disturbance'</a> above and <a class="local">'Neuroimaging'</a> above.)</p><p>Patients are at risk for the development of psychiatric disorders, most commonly mood disorders (other than bipolar disorder) and anxiety. In a study of 115 patients with KLS, psychiatric disorders were diagnosed in 20 percent of patients over one to six years of follow-up [<a href="#rid76">76</a>]. Females and patients with a long disease course are at highest risk. It is not known whether emergent psychiatric disorders are the consequence of psychiatric symptoms during episodes or a result of difficulty adjusting to KLS.</p><p class="headingAnchor" id="H1822624682"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of Kleine-Levin syndrome (KLS) is made based on the clinical features of episodic hypersomnia with typical cognitive and behavioral disturbances and exclusion of alternative psychiatric, neurologic, and toxic or metabolic etiologies.</p><p class="headingAnchor" id="H11387425"><span class="h2">Evaluation</span><span class="headingEndMark"> — </span>KLS is a rare disorder that should be suspected in adolescents, particularly males, who present with episodic hypersomnia, cognitive disturbance, and behavioral changes with a return to baseline between attacks. (See <a class="local">'Clinical features'</a> above.)</p><p>Because of the rarity of the syndrome and the nonspecific nature of some of the symptoms, all patients should undergo intensive investigation to exclude alternative psychiatric, neurologic, and toxic or metabolic etiologies. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History</strong> – The evaluation should include a comprehensive medical history from both the patient and household members for verification, since patients are commonly amnesic for episodes. Particular attention should be given to cognitive and behavioral changes associated with the episodes, provocative factors, prescribed medications, and drugs of abuse. Videos of the patient's behavior during episodes are useful. Sleep logs are also useful, supplemented by data from validated sleep/wake wearable devices when available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – The physical examination should include detailed neurologic and psychiatric examinations. The physical examination is normal in patients with KLS, and there are no specific neurologic findings. Although some patients report fever, headache, and photophobia, nuchal rigidity or focal neurologic signs have not been observed during or in between episodes [<a href="#rid3">3</a>], and the presence of such abnormalities should prompt consideration of an alternative diagnosis such as meningitis or encephalitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Brain imaging</strong> – Brain imaging with and without contrast should be obtained as part of the initial evaluation to exclude alternative structural etiologies. MRI is preferable to CT, based on the higher resolution and sensitivity of MRI for a variety of structural brain pathologies. </p><p></p><p class="bulletIndent1">When possible, we obtain brain functional imaging using positron emission tomography (PET) during asymptomatic periods to look for hypometabolism in associative posterior cortex or hippocampus. This finding is present in approximately 70 percent of patients during asymptomatic periods and hence it has good sensitivity to support the diagnosis of KLS, especially during the first years of the disorder [<a href="#rid107">107</a>]. (See <a class="local">'Neuroimaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>EEG and polysomnography</strong> – An electroencephalogram (EEG) during an episode may be helpful if aspects of the history are suggestive of seizure and is supportive of KLS when focal or global EEG slowing is identified. Polysomnography performed during an episode may show increased total sleep time but is otherwise nonspecific; the purpose is primarily to exclude alternative sleep disorders that may explain or contribute to excessive daytime sleepiness. (See <a class="local">'Laboratories and studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratories</strong> – Additional laboratory testing should be tailored to the presenting symptoms and the differential diagnosis; there are no characteristic cerebrospinal fluid (CSF), blood, or urine abnormalities in patients with KLS. Tests to consider include lumbar puncture for CSF analysis (including neuronal antibodies); blood tests to rule out possible causes of metabolic encephalopathy such as complete blood count, blood urea nitrogen, creatinine, liver function tests, ammonia, lactic and pyruvic acids, amino acids, acylcarnitine, toxicology screen, lead level, vitamin B12, folate, thyroid-stimulating hormone, and antithyroglobulin; and urine for toxicology screen, organic acids, and porphobilinogen. Serologic markers for specific pathogens (eg, Lyme) should be considered in selected cases. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="headingAnchor" id="H619136791"><span class="h2">Diagnostic criteria</span><span class="headingEndMark"> — </span>According to the third edition of the International Classification of Sleep Disorders, text revision (ICSD-3-TR), diagnostic criteria for KLS include all of the following  (<a class="graphic graphic_table graphicRef98217" href="/d/graphic/98217.html" rel="external">table 2</a>) [<a href="#rid53">53</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>At least two episodes of excessive sleepiness and sleep duration, each lasting for two days to five weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Episodes recur at least once every 18 months and usually more than once a year.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal or near-normal sleep and wakefulness, cognition, behavior, and mood between episodes, at least during the first years of the syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At least one of the following during episodes: cognitive dysfunction, derealization, major apathy, or disinhibited behavior (such as hypersexuality or hyperphagia).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypersomnolence and related symptoms are not better explained by another sleep disorder; other medical, neurologic, or psychiatric disorder (especially bipolar disorder); or use of drugs or medications.</p><p></p><p>Menstrual recurrent hypersomnia (MRH) is classified as a clinical subtype of KLS in which episodes are exclusively associated with menstruation [<a href="#rid53">53</a>]. (See <a class="local">'Menstrual recurrent hypersomnia'</a> above.)</p><p class="headingAnchor" id="H961052"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of KLS includes a variety of psychiatric, neurologic, and sleep disorders. Importantly, most of these are much more common than KLS and usually can be distinguished by clinical features, neuroimaging, polysomnography, and lumbar puncture.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychiatric disorders</strong> — Psychiatric disorders are the major differential diagnosis for KLS. Specific disorders that should be considered include depression, bipolar disorder, psychogenic/somatic hypersomnia, and acute psychosis. Features that may help distinguish KLS from psychiatric disorders include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>KLS patients generally do not report psychiatric symptoms between episodes and do not have significant family history for these disorders [<a href="#rid4">4</a>]. This contrasts with bipolar disorder, depression, or schizophrenia, in which symptoms are persistent and a family history is often present.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Compared with psychiatric disorders, the onset and offset of symptoms in KLS are much more abrupt (few hours to one to two days), and the length of episodes is shorter and more stereotyped.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Although hypersomnia may be reported by patients with depression, in the latter the symptom is more often increased time in bed (clinophilia) with depressed mentation rather than true hypersomnia (increased sleep). Severe cognitive disturbances when awake, including confusion and partial amnesia as described in KLS, are also a distinguishing feature from depression. (See <a class="local">'Cognitive disturbance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic disorders</strong> — In the midst of an episode, particularly if it is the first, numerous neurologic disorders may be considered on the differential diagnosis.</p><p></p><p class="bulletIndent1">One or more of the cardinal symptoms of KLS could be caused by structural pathology in the hypothalamus, frontal and/or temporal lobes, such as tumors (eg, craniopharyngioma, glioma, pinealoma, meningioma, colloid cyst), stroke, or inflammation/demyelination (eg, infectious, autoimmune, or paraneoplastic encephalitis, acute disseminated encephalomyelitis, multiple sclerosis). In contrast with KLS, however, neurologic symptoms caused by all of these processes are persistent, and patients often have additional findings on neurologic examination. Cystic tumors or colloid cysts within the third ventricle, which may cause episodic symptoms due to a ball-valve mechanism of obstruction, can be distinguished from KLS due to additional symptoms of increased intracranial pressure (headache, nausea, vomiting).</p><p></p><p class="bulletIndent1">The episodic nature of the symptoms in KLS may raise the possibility of epilepsy, particularly temporal lobe epilepsy or nonconvulsive status epilepticus. However, cardinal features of KLS, including prolonged periods (days) of derealization, hypersomnia, hyperphagia, and hypersexuality, are not typical for epilepsy. An EEG performed during an episode can often distinguish between KLS and epilepsy if the two cannot be distinguished clinically.</p><p></p><p class="bulletIndent1">Patients with Lewy Body dementia may have fluctuations of alertness associated with behavioral disturbances, but they are much older than KLS patients, have permanent cognitive deficits, and often have associated Parkinsonism. (See  <a class="medical medical_review" href="/d/html/5088.html" rel="external">"Clinical features and diagnosis of dementia with Lewy bodies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other sleep disorders</strong> — Excessive daytime sleepiness is also a major symptom of obstructive sleep apnea, delayed sleep phase syndrome, narcolepsy, and idiopathic hypersomnia. However, the clinical picture in all of these entities is neither episodic nor characterized by such severe cognitive or behavioral problems. Sleep time may mildly fluctuate in patients with these syndromes, however; hence, polysomnography is generally indicated in those with residual sleepiness during asymptomatic periods to exclude an alternative sleep disorder. (See  <a class="medical medical_review" href="/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness", section on 'Initial evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic encephalopathy or intoxication</strong> — Less common causes of recurrent hypersomnia are benzodiazepine intoxication, drug and alcohol overdoses or abuse, and recurrent metabolic encephalopathies due to hyperammonemia, aminoaciduria, or organic acidemia. A metabolic encephalopathy should be suspected in young children with developmental regression, failure to thrive, recurrent vomiting, and a positive family history of developmental delay or consanguinity. Some metabolic encephalopathies can produce increased intracranial pressure and acidosis (eg, papilledema, pyramidal signs, Kussmaul breathing), which should not be present in patients with KLS.</p><p></p><p class="headingAnchor" id="H11387473"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The etiology of Kleine-Levin syndrome (KLS) is unknown, and treatment during episodes of hypersomnia is primarily supportive. Patients with severe anxiety and psychosis should be treated symptomatically with appropriate medications and screened for suicidal ideation.</p><p>For patients with a history of prolonged or frequent episodes, <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> is the best studied maintenance agent to reduce the frequency and duration of episodes [<a href="#rid114">114,115</a>]. In patients with previous long episodes (&gt;30 days), a trial of intravenous (IV) glucocorticoids may be administered at the beginning of a new episode.</p><p class="headingAnchor" id="H4039060262"><span class="h2">Supportive care during episodes</span><span class="headingEndMark"> — </span>Our approach involves educating family members, caregivers, and occasionally teachers about the core symptoms of KLS and providing conditions so that patients will not injure themselves during episodes of hypersomnia [<a href="#rid116">116</a>].</p><p>The best course for most patients is to allow the patient to sleep in a safe and familiar environment, avoid driving, and be observed for medical and psychiatric complications. Patients are generally exhausted during attacks, and sleep is often the least harmful way to wait for the episode to end.</p><p class="headingAnchor" id="H1538776521"><span class="h3">Anxiety, suicidal ideation, and psychosis</span><span class="headingEndMark"> — </span>Patients with disabling anxiety, suicidality, and potentially dangerous delusions and behavioral disturbances should be evaluated by psychiatry clinicians to assess risk of harm to self and others; hospitalization is sometimes necessary to protect the patient.</p><p>Severe anxiety and psychosis associated with KLS episodes should be treated symptomatically. Anxiety can be intense during some episodes; in our practice, we use either <a class="drug drug_general" data-topicid="8544" href="/d/drug information/8544.html" rel="external">hydroxyzine</a> or a benzodiazepine as needed.</p><p>For patients with sustained and prominent psychosis, we suggest an atypical antipsychotic agent such as <a class="drug drug_general" data-topicid="9868" href="/d/drug information/9868.html" rel="external">risperidone</a>. Dosing should be individualized according to symptom severity, clinical response, and side effects. Most patients can be tapered off once symptoms improve.</p><p class="headingAnchor" id="H3460822199"><span class="h3">Hypersomnia and apathy</span><span class="headingEndMark"> — </span>In our experience, symptomatic therapies such as stimulants are ineffective for hypersomnia during KLS episodes, and many patients do not tolerate them due to excess anxiety. Therefore, we suggest <strong>not</strong> using stimulants and other medications in most patients with KLS. Most patients feel better by sleeping rather than by being artificially awakened by the stimulant, only to experience the other symptoms.</p><p>The evidence base for symptomatic therapies consists of case reports and retrospective, uncontrolled series, with no single agent showing consistent benefits [<a href="#rid3">3-5,30,117-128</a>]. A summary of subjective patient responses to a variety of symptomatic drug trials compiled from two observational series is provided in the table  (<a class="graphic graphic_table graphicRef98219" href="/d/graphic/98219.html" rel="external">table 3</a>). Due to the unpredictable course of the disease and the paucity of consistent positive results, reports should be interpreted cautiously. Specifically:</p><p class="bulletIndent1"><span class="glyph">●</span>Antidepressants – In our experience, antidepressants have no effect on symptom severity or episode frequency.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stimulants – Stimulants (eg, <a class="drug drug_general" data-topicid="9638" href="/d/drug information/9638.html" rel="external">methylphenidate</a>) and nonamphetamine wakefulness promoting agents (eg, <a class="drug drug_general" data-topicid="10157" href="/d/drug information/10157.html" rel="external">modafinil</a>, <a class="drug drug_general" data-topicid="9260" href="/d/drug information/9260.html" rel="external">armodafinil</a>) may have modest benefits in select patients but they do not address more bothersome symptoms of derealization, apathy, and cognitive disturbance, and they often increase anxiety [<a href="#rid3">3</a>]. If a stimulant is used, patients should be monitored for potential toxicities and unintended side effects such as exacerbation of anxiety, hypersexuality, aggression, or hallucinations [<a href="#rid129">129</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8508" href="/d/drug information/8508.html" rel="external">Amantadine</a> – Amantadine has dopaminergic, stimulant, and antiviral properties. Possible benefit in KLS was suggested by one observational study, in which 10 of 24 patients treated with amantadine on day 1 of an episode were reported to experience episode termination or improved cognitive symptoms [<a href="#rid3">3</a>]. In our experience with amantadine in more than 100 patients with KLS, however, this effect could not be replicated [<a href="#rid7">7</a>].</p><p></p><p>Other therapies that probably lack benefit in patients with KLS include <a class="drug drug_general" data-topicid="8456" href="/d/drug information/8456.html" rel="external">flumazenil</a> (a benzodiazepine receptor antagonist), electroconvulsive therapy, and insulin coma therapy [<a href="#rid3">3,44,45,71,75,82,130</a>]. <a class="drug drug_general" data-topicid="8817" href="/d/drug information/8817.html" rel="external">Sodium oxybate</a>, a metabolite of gamma amino butyric acid (GABA) that induces deep sedation and is used in patients with narcolepsy and idiopathic hypersomnia, has not been well studied in KLS. One case report described clinical improvement in a patient with KLS treated with sodium oxybate, but interpretation is difficult because there was no challenge of cessation and readministration [<a href="#rid122">122</a>].</p><p class="headingAnchor" id="H4074133900"><span class="h3">Headache</span><span class="headingEndMark"> — </span>Headaches can be problematic during episodes. Many patients respond to simple analgesics like <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a>. For patients who do respond, we have had anecdotal success with <a class="drug drug_general" data-topicid="9268" href="/d/drug information/9268.html" rel="external">acetazolamide</a> 250 to 500 mg per day.</p><p class="headingAnchor" id="H1204684349"><span class="h3">Prolonged episodes</span><span class="headingEndMark"> — </span>Up to one-third of patients have prolonged episodes (&gt;30 days) that are disabling and tend to be associated with more anxiety and agitation than shorter episodes [<a href="#rid7">7</a>]. Based on the authors' experience, one option to consider in these patients is a trial of high-dose glucocorticoids at the time of the next episode. We prefer IV <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a> 1 g daily for three consecutive days, beginning within 10 days of the onset of symptoms. When it is impossible to provide IV methylprednisolone, we use an oral taper (eg, <a class="drug drug_general" data-topicid="9809" href="/d/drug information/9809.html" rel="external">prednisone</a> 60 mg daily for two days, then 40 mg daily for two days, then 20 mg daily for two days). If glucocorticoid treatment is successful in shortening the duration or severity of the episode compared with prior episodes, we repeat with each future episode.</p><p>The potential benefit of glucocorticoids is supported by a retrospective study in which 26 patients with long episodes (&gt;30 days) received IV <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a> 1 g/day for three days during one to six episodes [<a href="#rid131">131</a>]. When each patient's preceding untreated episode duration was used as a comparison, 42 percent of patients experienced shorter episodes (by seven days or more) with steroid treatment. Receipt of steroids within the first 10 days of the onset of symptoms was associated with a greater likelihood of response (60 percent). Among a cohort of 48 contemporaneous patients with KLS who did not receive glucocorticoids and who were matched with treated patients by age, sex, disease duration, and number of episodes, the rate of spontaneous improvement of seven days or more from one episode to the next was only 10 percent. Steroids were well tolerated aside from transient insomnia and did not induce mania.</p><p>Although short-term, high-dose glucocorticoids are relatively safe and associated with few side effects in most patients, potential complications include hyperglycemia, increased susceptibility to infection, bone loss and fractures, and neuropsychiatric side effects. (See  <a class="medical medical_review" href="/d/html/7988.html" rel="external">"Major adverse effects of systemic glucocorticoids"</a>.)</p><p class="headingAnchor" id="H1503779121"><span class="h2">Prevention of new episodes</span></p><p class="headingAnchor" id="H1537547435"><span class="h3">Avoid precipitating factors</span><span class="headingEndMark"> — </span>In an effort to prevent new episodes, we advise patients avoid alcohol intake, use good hand hygiene, avoid direct contact with individuals who are infectious if possible, and sleep with regular schedules.</p><p class="headingAnchor" id="H966132"><span class="h3">Frequent episodes: Role of lithium</span><span class="headingEndMark"> — </span>There are no established therapies for episode prophylaxis in patients with KLS, but a variety of drugs with potential mood stabilizing effects (eg, <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a>, antiepileptic drugs, other miscellaneous agents) have been explored. In our experience, lithium is the most likely to be beneficial in patients with frequent episodes (eg, 4 to 12 episodes per year). Use of lithium for KLS is endorsed by the American Academy of Sleep Medicine (AASM) guidelines based on low-quality evidence [<a href="#rid114">114</a>].</p><p>In two large systematic, retrospective collections of case series that together included 59 patients treated with <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a>, 22 percent reported at least mild improvement in episode frequency, and 24 percent reported clear benefit [<a href="#rid3">3,4</a>]. In a larger single-center observational study of 130 patients with KLS regularly followed up, 37 percent of patients treated with lithium (26 out of 71) experienced complete resolution of episodes over a mean follow-up of 22 months, compared with 3 percent of contemporaneous patients who were not treated with lithium [<a href="#rid132">132</a>]. Another 46 percent of patients had a reduction of episode frequency, duration, or intensity, and 17 percent had no change of these markers using lithium ("lithium-resistant" patients). Ten percent of patients had no more full-blown episodes but rare "mini-KLS episodes" of half a day to one day when treated with lithium. The time spent incapacitated was one month lower per year in treated versus untreated patients. One or more side effects of lithium were reported by 50 percent of patients but were generally mild and led to treatment discontinuation in only 7 percent. The most common side effects were tremor, increased drinking, acne, diarrhea, and subclinical hypothyroidism (11 percent; only two patients required <a class="drug drug_general" data-topicid="9557" href="/d/drug information/9557.html" rel="external">levothyroxine</a>).</p><p>In various series, the effective dose range of <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a> (slow-release form) is 600 to 2000 mg at bed time (to achieve serum levels of 0.8 to 1.2 mmol/L when collected 12 hours after intake). The required concentrations are in the recommended range for bipolar disorder. Higher doses of lithium can have serious side effects (eg, thyroid and renal toxicities), and the risk-to-benefit ratio should be reassessed every six months. In some reports, episodes have recurred after two days of missed doses of lithium, highlighting the potential importance of adherence to therapy and providing some evidence of benefit [<a href="#rid116">116,132</a>]. The pharmacology, administration, and side effects of lithium are reviewed in more detail elsewhere. (See  <a class="medical medical_review" href="/d/html/15317.html" rel="external">"Bipolar disorder in adults and lithium: Pharmacology, administration, and management of adverse effects"</a>.)</p><p>More limited and less consistent results have been described with <a class="drug drug_general" data-topicid="10035" href="/d/drug information/10035.html" rel="external">valproate</a> and <a class="drug drug_general" data-topicid="9198" href="/d/drug information/9198.html" rel="external">carbamazepine</a> [<a href="#rid3">3,4</a>].</p><p class="headingAnchor" id="H1526604462"><span class="h2">Residual symptoms in between episodes</span><span class="headingEndMark"> — </span>Over time, some patients develop very mild residual symptoms during "asymptomatic" periods, including mild apathy or brief episodes of derealization, fatigue, residual sleepiness, and cognitive slowing. (See <a class="local">'Clinical course'</a> above.)</p><p>This stage of the disorder requires further study. In our experience, repeated courses of glucocorticoids do <strong>not</strong> alleviate these symptoms; in this way, the course bears similarity to the secondary progressive form of multiple sclerosis [<a href="#rid131">131</a>].</p><p class="headingAnchor" id="H1528217720"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Kleine-Levin syndrome (KLS) is a rare sleep disorder characterized by relapsing-remitting episodes of hypersomnia and cognitive disturbances, including apathy and derealization. KLS is a central disorder of hypersomnolence. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/d/html/7700.html" rel="external">"Classification of sleep disorders"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – The etiology of KLS is unknown. Contemporary hypotheses have focused primarily on developmental and genetic risk factors and immune/inflammatory causes. (See <a class="local">'Etiology and pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – The median age of onset is 16 years, and there is a male predominance. Episodes tend to progress rapidly, within hours to days, and symptoms last for a median of 10 days. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardinal symptoms</strong> – Episodic hypersomnia is a defining feature of KLS. Additional symptoms present in most patients during episodes of hypersomnia include cognitive disturbances, an altered perceptive state (derealization), and prominent apathy. Hyperphagia and hypersexuality are variably present. (See <a class="local">'Cardinal symptoms'</a> above.)</p><p></p><p class="bulletIndent2">Additional symptoms that may be reported during episodes include mood disturbances, anxiety, hallucinations and delusions, and compulsive behaviors. (See <a class="local">'Others'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical course</strong> – In between episodes, most patients with KLS return to a normal baseline and are generally indistinguishable from controls on measures of sleep, cognition, and mood. Over time, patients are at increased risk for mild neurocognitive impairment and emergent psychiatric disorders. (See <a class="local">'Clinical course'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of KLS is made based on the clinical features of episodic hypersomnia with typical cognitive and behavioral disturbances  (<a class="graphic graphic_table graphicRef98217" href="/d/graphic/98217.html" rel="external">table 2</a>) and exclusion of alternative psychiatric, neurologic, and toxic or metabolic etiologies. In between episodes, we suggest brain positron emission tomography (PET), where available, to assess for regional hypometabolism in the posterior associated cortex or hippocampus, which is supportive of the diagnosis of KLS. (See <a class="local">'Evaluation'</a> above and <a class="local">'Diagnostic criteria'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of KLS includes a variety of psychiatric, neurologic, and sleep disorders, most of which are much more common than KLS. Most can be distinguished by clinical features, structural neuroimaging, EEG, polysomnography, and lumbar puncture in selected cases. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management during episodes</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonpharmacologic management, which includes establishing a safe sleeping environment, educating caregivers and teachers, and monitoring for medical and psychiatric complications, is the mainstay of therapy for all patients. (See <a class="local">'Supportive care during episodes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with disabling anxiety, suicidal ideation, or potentially dangerous delusions and behavioral disturbances should be evaluated by psychiatry clinicians to assess risk of harm to self and others; hospitalization is sometimes necessary. Severe anxiety and psychosis associated with KLS episodes should be treated symptomatically with benzodiazepines and antipsychotic agents, as appropriate. (See <a class="local">'Anxiety, suicidal ideation, and psychosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest <strong>not</strong> treating with stimulants (eg, <a class="drug drug_general" data-topicid="9638" href="/d/drug information/9638.html" rel="external">methylphenidate</a>) or nonamphetamine wakefulness promoting agents (eg, <a class="drug drug_general" data-topicid="10157" href="/d/drug information/10157.html" rel="external">modafinil</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Most patients feel better by sleeping, and stimulants are poorly tolerated due to increased anxiety. (See <a class="local">'Hypersomnia and apathy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with a history of a prolonged episode (&gt;30 days), we suggest a trial of high-dose glucocorticoids at the onset of the next episode (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). If steroids shorten the duration or severity of the episode compared with prior episodes, we repeat with each future episode. (See <a class="local">'Prolonged episodes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention of episodes</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We advise patients to avoid alcohol intake, use good hand hygiene, avoid direct contact with individuals who are infectious if possible, and sleep with regular schedules. (See <a class="local">'Avoid precipitating factors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with frequent episodes, <a class="drug drug_general" data-topicid="9566" href="/d/drug information/9566.html" rel="external">lithium</a>, <a class="drug drug_general" data-topicid="10035" href="/d/drug information/10035.html" rel="external">valproate</a> and <a class="drug drug_general" data-topicid="9198" href="/d/drug information/9198.html" rel="external">carbamazepine</a> have been explored. Among these, for patients with frequent (eg, 4 to 12 per year), disabling, or prolonged episodes, we suggest treatment with lithium (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Frequent episodes: Role of lithium'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Residual symptoms in between episodes</strong> — 20 to 30 percent of patients with KLS develop mild cognitive impairment or psychiatric comorbidities that require appropriate assessment and care. (See <a class="local">'Residual symptoms in between episodes'</a> above.)</p><p></p><p class="headingAnchor" id="H3991645127"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Ruth S Shalev, MD, and Adi Aran, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gadoth N, Kesler A, Vainstein G, et al. Clinical and polysomnographic characteristics of 34 patients with Kleine-Levin syndrome. J Sleep Res 2001; 10:337.</a></li><li><a class="nounderline abstract_t">Dauvilliers Y, Mayer G, Lecendreux M, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology 2002; 59:1739.</a></li><li><a class="nounderline abstract_t">Arnulf I, Zeitzer JM, File J, et al. Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain 2005; 128:2763.</a></li><li><a class="nounderline abstract_t">Arnulf I, Lin L, Gadoth N, et al. Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol 2008; 63:482.</a></li><li><a class="nounderline abstract_t">Billiard M, Jaussent I, Dauvilliers Y, Besset A. Recurrent hypersomnia: a review of 339 cases. Sleep Med Rev 2011; 15:247.</a></li><li><a class="nounderline abstract_t">Huang YS, Guilleminault C, Lin KL, et al. Relationship between Kleine-Levin syndrome and upper respiratory infection in Taiwan. Sleep 2012; 35:123.</a></li><li><a class="nounderline abstract_t">Lavault S, Golmard JL, Groos E, et al. Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol 2015; 77:529.</a></li><li><a class="nounderline abstract_t">Katz JD, Ropper AH. Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells. Arch Neurol 2002; 59:1959.</a></li><li><a class="nounderline abstract_t">Peraita-Adrados R, Vicario JL, Tafti M, et al. Monozygotic twins affected with Kleine-Levin syndrome. Sleep 2012; 35:595.</a></li><li><a class="nounderline abstract_t">Ueno T, Fukuhara A, Ikegami A, et al. Monozygotic twins concordant for Kleine-Levin syndrome. BMC Neurol 2012; 12:31.</a></li><li><a class="nounderline abstract_t">BaHammam AS, GadElRab MO, Owais SM, et al. Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome. Sleep Med 2008; 9:575.</a></li><li><a class="nounderline abstract_t">Rocamora R, Gil-Nagel A, Franch O, Vela-Bueno A. Familial recurrent hypersomnia: two siblings with Kleine-Levin syndrome and menstrual-related hypersomnia. J Child Neurol 2010; 25:1408.</a></li><li><a class="nounderline abstract_t">Janicki S, Franco K, Zarko R. A case report of Kleine-Levin syndrome in an adolescent girl. Psychosomatics 2001; 42:350.</a></li><li><a class="nounderline abstract_t">Poppe M, Friebel D, Reuner U, et al. The Kleine-Levin syndrome - effects of treatment with lithium -. Neuropediatrics 2003; 34:113.</a></li><li><a class="nounderline abstract_t">Bonkalo A. Hypersomnia. A discussion of psychiatric implications based on three cases. Br J Psychiatry 1968; 114:69.</a></li><li><a class="nounderline abstract_t">Suwa K, Toru M. A case of periodic somnolence whose sleep was induced by glucose. Folia Psychiatr Neurol Jpn 1969; 23:253.</a></li><li><a class="nounderline abstract_t">Thacore VR, Ahmed M, Oswald I. The EEG in a case of periodic hypersomnia. Electroencephalogr Clin Neurophysiol 1969; 27:605.</a></li><li><a class="nounderline abstract_t">Nguyen QT, Groos E, Leclair-Visonneau L, et al. Familial Kleine-Levin Syndrome: A Specific Entity? Sleep 2016; 39:1535.</a></li><li><a class="nounderline abstract_t">Al Shareef SM, Basit S, Li S, et al. Kleine-Levin syndrome is associated with LMOD3 variants. J Sleep Res 2019; 28:e12718.</a></li><li><a class="nounderline abstract_t">Ambati A, Hillary R, Leu-Semenescu S, et al. Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci. Proc Natl Acad Sci U S A 2021; 118.</a></li><li><a class="nounderline abstract_t">Vaillant G, Martin M, Groos E, et al. A strange New Year's Eve: triggers in Kleine-Levin syndrome. J Clin Sleep Med 2021; 17:329.</a></li><li><a class="nounderline abstract_t">Cheung G. Posttraumatic Kleine-Levin syndrome. Gen Hosp Psychiatry 2006; 28:443.</a></li><li><a class="nounderline abstract_t">Pelin Z, Oztürk L, Bozluolcay M. Posttraumatic Kleine-Levin syndrome: a case report. Eur Psychiatry 2004; 19:521.</a></li><li><a class="nounderline abstract_t">Kostic VS, Stefanova E, Svetel M, Kozic D. A variant of the Kleine-Levin syndrome following head trauma. Behav Neurol 1998; 11:105.</a></li><li><a class="nounderline abstract_t">Billiard M, Podesta C. Recurrent hypersomnia following traumatic brain injury. Sleep Med 2013; 14:462.</a></li><li><a class="nounderline abstract_t">Smolík P, Roth B. Kleine-Levin syndrome ethiopathogenesis and treatment. Acta Univ Carol Med Monogr 1988; 128:5.</a></li><li><a class="nounderline abstract_t">Arnulf I, Groos E, Dodet P. Speculating on Kleine-Levin Syndrome mechanisms. J Clin Sleep Med 2021; 17:611.</a></li><li><a class="nounderline abstract_t">Haugh RM, Markesbery WR. Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function. Arch Neurol 1983; 40:560.</a></li><li><a class="nounderline abstract_t">Mendez G, Ozpinar A, Raskin J, et al. Case comparison and literature review of glioblastoma: A tale of two tumors. Surg Neurol Int 2014; 5:121.</a></li><li><a class="nounderline abstract_t">Itokawa K, Fukui M, Ninomiya M, et al. Gabapentin for Kleine-Levin syndrome. Intern Med 2009; 48:1183.</a></li><li><a class="nounderline abstract_t">Das A, Radhakrishnan A. A case of PANDAS with Kleine-Levin type periodic hypersomnia. Sleep Med 2012; 13:319.</a></li><li><a class="nounderline abstract_t">Kodaira M, Yamamoto K. First attack of Kleine-Levin syndrome triggered by influenza B mimicking influenza-associated encephalopathy. Intern Med 2012; 51:1605.</a></li><li><a class="nounderline abstract_t">Shukla GD, Bajpai HS, Mishra DN. Kleine-levin syndrome: a case report from India. Br J Psychiatry 1982; 141:97.</a></li><li><a class="nounderline abstract_t">Gallinek A. The Kleine-Levin syndrome. Dis Nerv Syst 1967; 28:448.</a></li><li><a class="nounderline abstract_t">Marčić M, Marčić L, Marčić B. SARS-CoV-2 Infection Causes Relapse of Kleine-Levin Syndrome: Case Report and Review of Literature. Neurol Int 2021; 13:328.</a></li><li><a class="nounderline abstract_t">Mukaddes NM, Fateh R, Kilincaslan A. Kleine-Levin syndrome in two subjects with diagnosis of autistic disorder. World J Biol Psychiatry 2009; 10:969.</a></li><li><a class="nounderline abstract_t">Berthier ML, Santamaria J, Encabo H, Tolosa ES. Recurrent hypersomnia in two adolescent males with Asperger's syndrome. J Am Acad Child Adolesc Psychiatry 1992; 31:735.</a></li><li><a class="nounderline abstract_t">Carpenter S, Yassa R, Ochs R. A pathologic basis for Kleine-Levin syndrome. Arch Neurol 1982; 39:25.</a></li><li><a class="nounderline abstract_t">Koerber RK, Torkelson R, Haven G, et al. Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome. Neurology 1984; 34:1597.</a></li><li><a class="nounderline abstract_t">Takrani LB, Cronin D. Kleine-Levin syndrome in a female patient. Can Psychiatr Assoc J 1976; 21:315.</a></li><li><a class="nounderline abstract_t">Fenzi F, Simonati A, Crosato F, et al. Clinical features of Kleine-Levin syndrome with localized encephalitis. Neuropediatrics 1993; 24:292.</a></li><li><a class="nounderline abstract_t">Zhou Q. Kleine-Levin syndrome. Chin Clin Neurol 2004; 12:423.</a></li><li><a class="nounderline abstract_t">Badino R, Caja A, Del Conte I, et al. Kleine-Levin syndrome in an 82 year old man. Ital J Neurol Sci 1992; 13:355.</a></li><li><a class="nounderline abstract_t">GALLINEK A. The Kleine-Levin syndrome: hypersomnia, bulimia, and abnormal mental states. World Neurol 1962; 3:235.</a></li><li><a class="nounderline abstract_t">Yassa R, Nair NP. The Kleine-Levine syndrome--a variant? J Clin Psychiatry 1978; 39:254.</a></li><li><a class="nounderline abstract_t">Hegarty A, Merriam AE. Autonomic events in Kleine-Levin syndrome. Am J Psychiatry 1990; 147:951.</a></li><li><a class="nounderline abstract_t">Manni R, Martinetti M, Ratti MT, Tartara A. Electrophysiological and immunogenetic findings in recurrent monosymptomatic-type hypersomnia: a study of two unrelated Italian cases. Acta Neurol Scand 1993; 88:293.</a></li><li><a class="nounderline abstract_t">Kesler A, Gadoth N, Vainstein G, et al. Kleine Levin syndrome (KLS) in young females. Sleep 2000; 23:563.</a></li><li><a class="nounderline abstract_t">Sagar RS, Khandelwal SK, Gupta S. Interepisodic morbidity in Kleine-Levin syndrome. Br J Psychiatry 1990; 157:139.</a></li><li><a class="nounderline abstract_t">Hart EJ. Kleine-Levin syndrome: normal CSF monoamines and response to lithium therapy. Neurology 1985; 35:1395.</a></li><li><a class="nounderline abstract_t">Pike M, Stores G. Kleine-Levin syndrome: a cause of diagnostic confusion. Arch Dis Child 1994; 71:355.</a></li><li><a class="nounderline abstract_t">Fresco R, Blumen G, Tatossian A, Sutter JM. [2 cases of Kleine-Levin syndrome]. Rev Neuropsychiatr Infant 1970; :Suppl:55.</a></li><li class="breakAll">American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, text revision, American Academy of Sleep Medicine, 2023.</li><li><a class="nounderline abstract_t">Powers PS, Gunderman R. Kleine-Levin syndrome associated with fire setting. Am J Dis Child 1978; 132:786.</a></li><li><a class="nounderline abstract_t">Frank Y, Braham J, Cohen BE. The Kleine-Levin syndrome. Case report and review of the literature. Am J Dis Child 1974; 127:412.</a></li><li><a class="nounderline abstract_t">Prabhakaran N, Murthy GK, Mallya UL. A case of Kleine-Levin syndrome in India. Br J Psychiatry 1970; 117:517.</a></li><li><a class="nounderline abstract_t">Russell J, Grunstein R. Kleine-Levin syndrome: a case report. Aust N Z J Psychiatry 1992; 26:119.</a></li><li><a class="nounderline abstract_t">Fröscher W, Maier V, Fritschi T. Periodic hypersomnia: case report with biochemical and EEG findings. Sleep 1991; 14:460.</a></li><li><a class="nounderline abstract_t">Landtblom AM, Dige N, Schwerdt K, et al. Short-term memory dysfunction in Kleine-Levin syndrome. Acta Neurol Scand 2003; 108:363.</a></li><li><a class="nounderline abstract_t">Malhotra S, Das MK, Gupta N, Muralidharan R. A clinical study of Kleine-Levin syndrome with evidence for hypothalamic-pituitary axis dysfunction. Biol Psychiatry 1997; 42:299.</a></li><li><a class="nounderline abstract_t">Vigren P, Tisell A, Engström M, et al. Low thalamic NAA-concentration corresponds to strong neural activation in working memory in Kleine-Levin syndrome. PLoS One 2013; 8:e56279.</a></li><li><a class="nounderline abstract_t">Masi G, Favilla L, Millepiedi S. The Kleine-Levin syndrome as a neuropsychiatric disorder: a case report. Psychiatry 2000; 63:93.</a></li><li><a class="nounderline abstract_t">Körtner K, Hansen ML, Danker-Hopfe H, et al. Persistent deficits of visual recall in Kleine-Levin syndrome. J Clin Neurosci 2011; 18:439.</a></li><li><a class="nounderline abstract_t">Shi YT, Tang BS, Jiang H. Kleine-Levin syndrome with brain atrophy. J Clin Neurosci 2013; 20:1027.</a></li><li><a class="nounderline abstract_t">Uguccioni G, Lavault S, Chaumereuil C, et al. Long-Term Cognitive Impairment in Kleine-Levin Syndrome. Sleep 2016; 39:429.</a></li><li><a class="nounderline abstract_t">Mayer G, Leonhard E, Krieg J, Meier-Ewert K. Endocrinological and polysomnographic findings in Kleine-Levin syndrome: no evidence for hypothalamic and circadian dysfunction. Sleep 1998; 21:278.</a></li><li><a class="nounderline abstract_t">Green LN, Cracco RQ. Kleine-Levin syndrome. A case with EEG evidence of periodic brain dysfunction. Arch Neurol 1970; 22:166.</a></li><li><a class="nounderline abstract_t">Mukaddes NM, Alyanak B, Kora ME, Polvan O. The psychiatric symptomatology in Kleine-Levin syndrome. Child Psychiatry Hum Dev 1999; 29:253.</a></li><li><a class="nounderline abstract_t">Rosenow F, Kotagal P, Cohen BH, et al. Multiple sleep latency test and polysomnography in diagnosing Kleine-Levin syndrome and periodic hypersomnia. J Clin Neurophysiol 2000; 17:519.</a></li><li><a class="nounderline abstract_t">George HR. A case of the Kleine-Levin syndrome of long duration. Br J Psychiatry 1970; 117:521.</a></li><li><a class="nounderline abstract_t">Duffy JP, Davison K. A female case of the Kleine-Levin Syndrome. Br J Psychiatry 1968; 114:77.</a></li><li><a class="nounderline abstract_t">Shukla G, Bhatia M, Singh S, et al. Atypical Kleine--Levin syndrome: can insomnia and anorexia be features too? Sleep Med 2008; 9:172.</a></li><li><a class="nounderline abstract_t">Portilla P, Durand E, Chalvon A, et al. [SPECT-identified hypoperfusion of the left temporomesial structures in a Kleine-Levin syndrome]. Rev Neurol (Paris) 2002; 158:593.</a></li><li><a class="nounderline abstract_t">Salter MS, White PD. A variant of the Kleine-Levin syndrome precipitated by both Epstein-Barr and varicella-zoster virus infections. Biol Psychiatry 1993; 33:388.</a></li><li><a class="nounderline abstract_t">VLACH V. [Periodic somnolence, bulimia and mental disorder (Kleine-Levin syndrome)]. Cesk Neurol 1962; 25:401.</a></li><li><a class="nounderline abstract_t">Groos E, Chaumereuil C, Flamand M, et al. Emerging psychiatric disorders in Kleine-Levin syndrome. J Sleep Res 2018; 27:e12690.</a></li><li><a class="nounderline abstract_t">Crumley FE. Valproic acid for Kleine-Levin syndrome. J Am Acad Child Adolesc Psychiatry 1997; 36:868.</a></li><li><a class="nounderline abstract_t">Arnulf I, Lecendreux M, Franco P, Dauvilliers Y. [Kleine-Levin syndrome: state of the art]. Rev Neurol (Paris) 2008; 164:658.</a></li><li><a class="nounderline abstract_t">Reynolds CF 3rd, Black RS, Coble P, et al. Similarities in EEG sleep findings for Kleine-Levin syndrome and unipolar depression. Am J Psychiatry 1980; 137:116.</a></li><li><a class="nounderline abstract_t">Goldberg MA. The treatment of Kleine-Levin syndrome with lithium. Can J Psychiatry 1983; 28:491.</a></li><li><a class="nounderline abstract_t">Garland H, Sumner D, Fourman P. The Kleine-Levin syndrome. Some further observations. Neurology 1965; 15:1161.</a></li><li><a class="nounderline abstract_t">Chiles JA, Wilkus RJ. Behavioral manifestations of the Kleine-Levin syndrome. Dis Nerv Syst 1976; 37:646.</a></li><li><a class="nounderline abstract_t">Muratori F, Bertini N, Masi G. Efficacy of lithium treatment in Kleine-Levin syndrome. Eur Psychiatry 2002; 17:232.</a></li><li><a class="nounderline abstract_t">Papacostas SS, Hadjivasilis V. The Kleine-Levin syndrome. Report of a case and review of the literature. Eur Psychiatry 2000; 15:231.</a></li><li><a class="nounderline abstract_t">Will RG, Young JP, Thomas DJ. Kleine-Levin syndrome: report of two cases with onset of symptoms precipitated by head trauma. Br J Psychiatry 1988; 152:410.</a></li><li><a class="nounderline abstract_t">Jensen J. [The Kleine-Levin syndrome. Periodic hypersomnia and hyperphagia with abnormal behavior]. Ugeskr Laeger 1985; 147:709.</a></li><li><a class="nounderline abstract_t">Fukunishi I, Hosokawa K. A female case with the Kleine-Levin syndrome and its physiopathologic aspects. Jpn J Psychiatry Neurol 1989; 43:45.</a></li><li><a class="nounderline abstract_t">Gillberg C. Kleine-Levin syndrome: unrecognized diagnosis in adolescent psychiatry. J Am Acad Child Adolesc Psychiatry 1987; 26:793.</a></li><li><a class="nounderline abstract_t">Kleine W. Periodische schlafsucht. Monats Psychiatr Neurol 1925; 57:285.</a></li><li><a class="nounderline abstract_t">Billiard M, Guilleminault C, Dement WC. A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity? Neurology 1975; 25:436.</a></li><li><a class="nounderline abstract_t">Sachs C, Persson HE, Hagenfeldt K. Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology 1982; 32:1376.</a></li><li><a class="nounderline abstract_t">Billard C, Ponsot G, Lyon G, Arfel G. [Kleine-Levin syndrome. A propos of a case]. Arch Fr Pediatr 1978; 35:424.</a></li><li><a class="nounderline abstract_t">Da Silveira Neto O, Da Silveira OA. [Kleine-Levin syndrome. Report of a case]. Arq Neuropsiquiatr 1991; 49:330.</a></li><li><a class="nounderline abstract_t">Landtblom AM, Dige N, Schwerdt K, et al. A case of Kleine-Levin syndrome examined with SPECT and neuropsychological testing. Acta Neurol Scand 2002; 105:318.</a></li><li><a class="nounderline abstract_t">Hasegawa Y, Morishita M, Suzumura A. Novel chromosomal abberation in a patient with a unique sleep disorder. J Neurol Neurosurg Psychiatry 1998; 64:113.</a></li><li><a class="nounderline abstract_t">Maranci JB, Roze E, Benoist JF, et al. Dopamine and serotonin levels in cerebrospinal fluid during episodes of Kleine-Levin syndrome. Sleep Med 2017; 36:184.</a></li><li><a class="nounderline abstract_t">Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59:1553.</a></li><li><a class="nounderline abstract_t">Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003; 74:1667.</a></li><li><a class="nounderline abstract_t">Lopez R, Barateau L, Chenini S, Dauvilliers Y. Preliminary results on CSF biomarkers for hypothalamic dysfunction in Kleine-Levin syndrome. Sleep Med 2015; 16:194.</a></li><li><a class="nounderline abstract_t">Wang JY, Han F, Dong SX, et al. Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome. Sleep 2016; 39:855.</a></li><li><a class="nounderline abstract_t">Huang YS, Lin YH, Guilleminault C. Polysomnography in Kleine-Levin syndrome. Neurology 2008; 70:795.</a></li><li><a class="nounderline abstract_t">Lin C, Chin WC, Huang YS, et al. Different circadian rest-active rhythms in Kleine-Levin syndrome: a prospective and case-control study. Sleep 2021; 44.</a></li><li><a class="nounderline abstract_t">Ugoljew A, Kurella B, Nickel B. [Sleep polygraphic studies as an objective method for assessing the therapeutic result in a case of periodic hypersomnia (Kleine-Levin syndrome)]. Nervenarzt 1991; 62:292.</a></li><li><a class="nounderline abstract_t">Huang YS, Guilleminault C, Kao PF, Liu FY. SPECT findings in the Kleine-Levin syndrome. Sleep 2005; 28:955.</a></li><li><a class="nounderline abstract_t">Vigren P, Engström M, Landtblom AM. SPECT in the Kleine-Levin Syndrome, a Possible Diagnostic and Prognostic Aid? Front Neurol 2014; 5:178.</a></li><li><a class="nounderline abstract_t">Kas A, Lavault S, Habert MO, Arnulf I. Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome. Brain 2014; 137:2077.</a></li><li><a class="nounderline abstract_t">Dudoignon B, Tainturier LE, Dodet P, et al. Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine-Levin syndrome: an early marker? Brain Commun 2021; 3:fcab130.</a></li><li><a class="nounderline abstract_t">Engström M, Vigren P, Karlsson T, Landtblom AM. Working memory in 8 Kleine-Levin syndrome patients: an fMRI study. Sleep 2009; 32:681.</a></li><li><a class="nounderline abstract_t">Engström M, Landtblom AM, Karlsson T. Brain and effort: brain activation and effort-related working memory in healthy participants and patients with working memory deficits. Front Hum Neurosci 2013; 7:140.</a></li><li><a class="nounderline abstract_t">Engström M, Karlsson T, Landtblom AM. Thalamic activation in the Kleine-Levin syndrome. Sleep 2014; 37:379.</a></li><li><a class="nounderline abstract_t">Engström M, Karlsson T, Landtblom AM. Reduced thalamic and pontine connectivity in kleine-levin syndrome. Front Neurol 2014; 5:42.</a></li><li><a class="nounderline abstract_t">Fontenelle L, Mendlowicz MV, Gillin JC, et al. Neuropsychological sequelae in Kleine-Levin syndrome: case report. Arq Neuropsiquiatr 2000; 58:531.</a></li><li><a class="nounderline abstract_t">Fontenelle LF, Mendlowicz MV, Marques C, et al. Persistent neuropsychological deficits in the Kleine-Levin syndrome. Acta Neurol Scand 2003; 107:304.</a></li><li><a class="nounderline abstract_t">Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021; 17:1881.</a></li><li><a class="nounderline abstract_t">Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021; 17:1895.</a></li><li><a class="nounderline abstract_t">Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol 2012; 11:918.</a></li><li><a class="nounderline abstract_t">Yao CC, Lin Y, Liu HC, Lee CS. Effects of various drug therapies on Kleine-Levin syndrome: a case report. Gen Hosp Psychiatry 2013; 35:102.e7.</a></li><li><a class="nounderline abstract_t">Trotti LM, Bliwise DL, Rye DB. Further experience using clarithromycin in patients with Kleine-Levin syndrome. J Clin Sleep Med 2014; 10:457.</a></li><li><a class="nounderline abstract_t">Sveinsson O. A striking response to lithium in kleine-levin syndrome. Front Neurol 2014; 5:33.</a></li><li><a class="nounderline abstract_t">Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev 2013; :CD006685.</a></li><li><a class="nounderline abstract_t">Mignot EJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics 2012; 9:739.</a></li><li><a class="nounderline abstract_t">Ortega-Albás JJ, Díaz JR, López-Bernabé R, et al. Treatment of Kleine-Levin syndrome with sodium oxybate. Sleep Med 2011; 12:730.</a></li><li><a class="nounderline abstract_t">Aggarwal A, Garg A, Jiloha RC. Kleine-Levine syndrome in an adolescent female and response to modafinil. Ann Indian Acad Neurol 2011; 14:50.</a></li><li><a class="nounderline abstract_t">Surges R, Walker MC. A case of late-onset Kleine-Levin syndrome responding to lamotrigine. Sleep Med 2009; 10:394.</a></li><li><a class="nounderline abstract_t">Loganathan S, Manjunath S, Jhirwal OP, et al. Lithium prophylaxis in Kleine-Levin syndrome. J Neuropsychiatry Clin Neurosci 2009; 21:107.</a></li><li><a class="nounderline abstract_t">El Hajj T, Nasreddine W, Korri H, et al. A case of Kleine-Levin syndrome with a complete and sustained response to carbamazepine. Epilepsy Behav 2009; 15:391.</a></li><li><a class="nounderline abstract_t">Adlakha A, Chokroverty S. An adult onset patient with Kleine-Levin syndrome responding to valproate. Sleep Med 2009; 10:391.</a></li><li><a class="nounderline abstract_t">de Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev 2016; :CD006685.</a></li><li><a class="nounderline abstract_t">Hsieh CF, Lai CL, Lan SH, et al. Modafinil-associated vivid visual hallucination in a patient with Kleine-Levin syndrome: case report. J Clin Psychopharmacol 2010; 30:347.</a></li><li><a class="nounderline abstract_t">Savet JF, Robert H, Angeli C. [A case of Kleine-Levin syndrome stabilized for over 1 year with carbamazepine]. Presse Med 1986; 15:1281.</a></li><li><a class="nounderline abstract_t">Léotard A, Groos E, Chaumereuil C, et al. IV steroids during long episodes of Kleine-Levin syndrome. Neurology 2018; 90:e1488.</a></li><li><a class="nounderline abstract_t">Leu-Semenescu S, Le Corvec T, Groos E, et al. Lithium therapy in Kleine-Levin syndrome: An open-label, controlled study in 130 patients. Neurology 2015; 85:1655.</a></li></ol></div><div id="topicVersionRevision">Topic 14897 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11903864" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical and polysomnographic characteristics of 34 patients with Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12473762" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16230322" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Kleine-Levin syndrome: a systematic review of 186 cases in the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18438947" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Kleine-Levin syndrome: a systematic study of 108 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20970360" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Recurrent hypersomnia: a review of 339 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22215926" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Relationship between Kleine-Levin syndrome and upper respiratory infection in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25559212" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12470186" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22547884" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Monozygotic twins affected with Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22646233" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Monozygotic twins concordant for Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17761456" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20404354" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Familial recurrent hypersomnia: two siblings with Kleine-Levin syndrome and menstrual-related hypersomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11496026" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A case report of Kleine-Levin syndrome in an adolescent girl.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12910433" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The Kleine-Levin syndrome - effects of treatment with lithium -.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5636091" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Hypersomnia. A discussion of psychiatric implications based on three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5396056" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A case of periodic somnolence whose sleep was induced by glucose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4188786" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The EEG in a case of periodic hypersomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27253765" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Familial Kleine-Levin Syndrome: A Specific Entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29923248" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Kleine-Levin syndrome is associated with LMOD3 variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33737391" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33025902" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A strange New Year's Eve: triggers in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16950384" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Posttraumatic Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15589717" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Posttraumatic Kleine-Levin syndrome: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11568408" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A variant of the Kleine-Levin syndrome following head trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499199" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Recurrent hypersomnia following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3078227" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Kleine-Levin syndrome ethiopathogenesis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33416047" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Speculating on Kleine-Levin Syndrome mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6577819" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25140280" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Case comparison and literature review of glioblastoma: A tale of two tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19571456" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Gabapentin for Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22261244" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A case of PANDAS with Kleine-Levin type periodic hypersomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22728499" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : First attack of Kleine-Levin syndrome triggered by influenza B mimicking influenza-associated encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6956423" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Kleine-levin syndrome: a case report from India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4951979" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34294673" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : SARS-CoV-2 Infection Causes Relapse of Kleine-Levin Syndrome: Case Report and Review of Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18609443" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Kleine-Levin syndrome in two subjects with diagnosis of autistic disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1644738" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Recurrent hypersomnia in two adolescent males with Asperger's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6948538" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A pathologic basis for Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6209595" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/991067" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Kleine-Levin syndrome in a female patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8309520" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clinical features of Kleine-Levin syndrome with localized encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Kleine-Levin syndrome</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1601635" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Kleine-Levin syndrome in an 82 year old man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13896459" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The Kleine-Levin syndrome: hypersomnia, bulimia, and abnormal mental states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/273020" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The Kleine-Levine syndrome--a variant?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2356886" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Autonomic events in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8256576" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Electrophysiological and immunogenetic findings in recurrent monosymptomatic-type hypersomnia: a study of two unrelated Italian cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10875563" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Kleine Levin syndrome (KLS) in young females.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2397348" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Interepisodic morbidity in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4022394" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Kleine-Levin syndrome: normal CSF monoamines and response to lithium therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7979534" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Kleine-Levin syndrome: a cause of diagnostic confusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4949124" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : [2 cases of Kleine-Levin syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4949124" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : [2 cases of Kleine-Levin syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/210655" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Kleine-Levin syndrome associated with fire setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4814887" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The Kleine-Levin syndrome. Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5480699" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A case of Kleine-Levin syndrome in India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1580874" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Kleine-Levin syndrome: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1759099" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Periodic hypersomnia: case report with biochemical and EEG findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14616308" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Short-term memory dysfunction in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9270909" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A clinical study of Kleine-Levin syndrome with evidence for hypothalamic-pituitary axis dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23451038" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Low thalamic NAA-concentration corresponds to strong neural activation in working memory in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10855764" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The Kleine-Levin syndrome as a neuropsychiatric disorder: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21236684" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Persistent deficits of visual recall in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23664128" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Kleine-Levin syndrome with brain atrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26414895" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Long-Term Cognitive Impairment in Kleine-Levin Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9595606" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Endocrinological and polysomnographic findings in Kleine-Levin syndrome: no evidence for hypothalamic and circadian dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5262037" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Kleine-Levin syndrome. A case with EEG evidence of periodic brain dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10080967" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The psychiatric symptomatology in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11085556" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Multiple sleep latency test and polysomnography in diagnosing Kleine-Levin syndrome and periodic hypersomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5480700" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A case of the Kleine-Levin syndrome of long duration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5236057" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A female case of the Kleine-Levin Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17644478" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Atypical Kleine--Levin syndrome: can insomnia and anorexia be features too?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12072828" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : [SPECT-identified hypoperfusion of the left temporomesial structures in a Kleine-Levin syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8386007" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : A variant of the Kleine-Levin syndrome precipitated by both Epstein-Barr and varicella-zoster virus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13997569" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : [Periodic somnolence, bulimia and mental disorder (Kleine-Levin syndrome)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29655261" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Emerging psychiatric disorders in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9204661" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Valproic acid for Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18653203" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : [Kleine-Levin syndrome: state of the art].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6928091" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Similarities in EEG sleep findings for Kleine-Levin syndrome and unipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6416662" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The treatment of Kleine-Levin syndrome with lithium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5295527" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : The Kleine-Levin syndrome. Some further observations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/186243" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Behavioral manifestations of the Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12231271" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Efficacy of lithium treatment in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10951606" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The Kleine-Levin syndrome. Report of a case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3139128" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Kleine-Levin syndrome: report of two cases with onset of symptoms precipitated by head trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3856964" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : [The Kleine-Levin syndrome. Periodic hypersomnia and hyperphagia with abnormal behavior].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2739168" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A female case with the Kleine-Levin syndrome and its physiopathologic aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3478332" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Kleine-Levin syndrome: unrecognized diagnosis in adolescent psychiatry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Periodische schlafsucht</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/166331" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6890644" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Menstruation-related periodic hypersomnia: a case study with successful treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/278544" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : [Kleine-Levin syndrome. A propos of a case].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1807235" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : [Kleine-Levin syndrome. Report of a case].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11939946" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : A case of Kleine-Levin syndrome examined with SPECT and neuropsychological testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9436739" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Novel chromosomal abberation in a patient with a unique sleep disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28629702" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Dopamine and serotonin levels in cerebrospinal fluid during episodes of Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12374492" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14638887" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25454350" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Preliminary results on CSF biomarkers for hypothalamic dysfunction in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26943469" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18316691" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Polysomnography in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33851710" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Different circadian rest-active rhythms in Kleine-Levin syndrome: a prospective and case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1865960" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : [Sleep polygraphic studies as an objective method for assessing the therapeutic result in a case of periodic hypersomnia (Kleine-Levin syndrome)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16218078" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : SPECT findings in the Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25295028" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : SPECT in the Kleine-Levin Syndrome, a Possible Diagnostic and Prognostic Aid?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24785943" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34189461" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Functional brain imaging using 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in 138 patients with Kleine-Levin syndrome: an early marker?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19480235" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Working memory in 8 Kleine-Levin syndrome patients: an fMRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23616756" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Brain and effort: brain activation and effort-related working memory in healthy participants and patients with working memory deficits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24497666" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Thalamic activation in the Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24765085" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Reduced thalamic and pontine connectivity in kleine-levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10920418" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Neuropsychological sequelae in Kleine-Levin syndrome: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12675707" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Persistent neuropsychological deficits in the Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743789" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743790" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22995695" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Diagnosis, disease course, and management of patients with Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22520717" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Effects of various drug therapies on Kleine-Levin syndrome: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24733995" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Further experience using clarithromycin in patients with Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24711803" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : A striking response to lithium in kleine-levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23945927" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Pharmacological treatment for Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23065655" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : A practical guide to the therapy of narcolepsy and hypersomnia syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21763197" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Treatment of Kleine-Levin syndrome with sodium oxybate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21655207" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Kleine-Levine syndrome in an adolescent female and response to modafinil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18514022" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : A case of late-onset Kleine-Levin syndrome responding to lamotrigine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19359469" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Lithium prophylaxis in Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19447193" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : A case of Kleine-Levin syndrome with a complete and sustained response to carbamazepine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19062339" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : An adult onset patient with Kleine-Levin syndrome responding to valproate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27153153" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Pharmacological treatment for Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20473083" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Modafinil-associated vivid visual hallucination in a patient with Kleine-Levin syndrome: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2945184" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : [A case of Kleine-Levin syndrome stabilized for over 1 year with carbamazepine].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29572278" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : IV steroids during long episodes of Kleine-Levin syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26453648" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Lithium therapy in Kleine-Levin syndrome: An open-label, controlled study in 130 patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
